Skip to main content
Emergency Alert
emergency alert

Novant Health UVA Health System is now part of UVA Health. Learn about using UVAHealth.com

  • Find a Doctor
  • Services
  • Locations
  • Patients & Visitors
  • Appointments
  • Billing
  • Clinical Trials
  • MyChart

Locations Doctors
UVA Health Home
UVA Health
  • Appointments
  • Billing
  • Clinical Trials
  • Careers
  • MyChart
UVA Health Home
UVA Health
  • Find a Doctor
  • Services
  • Locations
  • Patients & Visitors
  • Search
  • Menu
  1. Home
  2. Clinical Trial Categories
  3. Clinical Trials
  • Find a Clinical Trial
    • Introduction to Clinical Trials Research
    • Clinical Trials FAQs
    • Clinical Trials Terminology
    • Submit a Trial for Advertisement

Surgery Clinical Trials

  • Colorectal Cancer
  • Study for Patients Planning to Undergo Abdominal Surgery for Colorectal, Hepatobiliary, or Gynecologic Cancer
  • Diabetes Type 1
  • Are you a type 1 diabetic with hypoglycemic unawareness?
  • Focused Ultrasound Surgery
  • Adults with one or more metastatic tumors who have tried or are not eligible for other therapies are invited to be in a research study that uses focused ultrasound ablation therapy (AM003)
  • Gynecologic Cancer
  • Study for Patients Planning to Undergo Abdominal Surgery for Colorectal, Hepatobiliary, or Gynecologic Cancer
  • Liver Cancer
  • Study for Patients Planning to Undergo Abdominal Surgery for Colorectal, Hepatobiliary, or Gynecologic Cancer
  • Lung Cancer
  • Lung Cancer Surgical Trial
  • Lymphomas
  • Study for Patients with Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma (CTCL) Comparing an Investigational Combination of Pembrolizumab (Keytruda) with Decitabine and/or Pralatrexate (PTCL 002)
  • Melanoma
  • Adults with stage IB – IV melanoma are invited to be in a research study testing a melanoma vaccine (Mel 66)
  • Peripheral T-Cell Lymphoma (PTCL)
  • Study for Patients with Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma (CTCL) Comparing an Investigational Combination of Pembrolizumab (Keytruda) with Decitabine and/or Pralatrexate (PTCL 002)
University of Virginia Health System
1215 Lee Street
Charlottesville, VA 22903 Map & Directions

UVA Health

  • About Us
  • Clinical Trials
  • News
  • Services
  • Quality & Safety

Community

  • Find a Job | Careers
  • Donate
  • Volunteer
  • Patient Referrals
  • Request Privileges

Patients & Visitors

  • Contact a Patient
  • Give Feedback
  • Medical Records
  • Pay your Bill
  • Getting Financial Assistance
Facebook
Facebook
Twitter
Twitter
Youtube
Youtube
Instagram
Instagram
Patient Rights & Policies | Web Privacy | Financial Interests | Report Accessibility Barrier |

© 2023 Rector and Visitors of the University of Virginia. All rights reserved.

  • UVA Children's
  • School of Medicine
  • School of Nursing
  • Physicians Group
  • Health Foundation
  • UVA